India's equity benchmark indices Sensex and Nifty experienced a significant drop in their early trade on Monday (24 February) ...

India's GDP may be impacted by proposed US tariffs raising by an estimated 0.1 to 0.6 percentage points, as per Goldman Sachs ...

India and Japan have a unique opportunity to gain from US tariffs, says Hero Enterprises' Sunil Kant Munjal. He believes ...

The Indian stock market has seen a dramatic downturn in 2025, with major indices losing substantial value. Investors are ...

Indian shares opened lower on Monday, mirroring global peers, as concerns over slowing U.S. growth added to the ongoing ...

Trump criticised the $21 million in USAID funding for India’s voter turnout. He raised concerns about transparency and ...

S&P Global Ratings reports that India, South Korea, and Thailand are most at risk of facing higher US tariffs under the Trump ...

The India-US ties will depend on India's readiness to be a willing partner in the American designs on China and what it will ...

Indian indices Sensex and Nifty opened lower, mirroring global market downturn fueled by US inflation concerns and FII ...

Zydus Lifesciences: The company and its subsidiaries received final approval from the United States Food and Drug Administration (US FDA) to manufacture Ibuprofen and Famotidine tablets, 800 mg/26.6 ...

A former KGB officer claims Donald Trump was recruited as a Russian spy in 1987, codenamed 'Krasnov'. Trump allegedly became ...

US President Donald Trump has ramped up his attack on USAID funds given to India, claiming the grant is misused to boost ...